Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleClinical Review

An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions

William Michael, Allison Diane Couture, Matthew Swedlund, Adrienne Hampton, Anne Eglash and Sarina Schrager
The Journal of the American Board of Family Medicine December 2022, 35 (6) 1217-1229; DOI: https://doi.org/10.3122/jabfm.2022.220115R1
William Michael
From Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin Madison, WI (WM, AC, MS, AH, AE, and SS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison Diane Couture
From Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin Madison, WI (WM, AC, MS, AH, AE, and SS).
DO, MPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Swedlund
From Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin Madison, WI (WM, AC, MS, AH, AE, and SS).
MD, MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne Hampton
From Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin Madison, WI (WM, AC, MS, AH, AE, and SS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Eglash
From Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin Madison, WI (WM, AC, MS, AH, AE, and SS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarina Schrager
From Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin Madison, WI (WM, AC, MS, AH, AE, and SS).
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Ellison DL,
    2. Moran HR
    . Vitamin D: vitamin or hormone? Nurs Clin North Am 2021;56:47–57.
    OpenUrl
  2. 2.↵
    1. Wang Y,
    2. Zhu J,
    3. DeLuca HF
    . Where is the vitamin D receptor? Arch Biochem Biophys 2012;523:123–33.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Cashman KD
    . Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int 2020;106:14–29.
    OpenUrlCrossRef
  4. 4.↵
    1. Schleicher RL,
    2. Sternberg MR,
    3. Looker AC,
    4. et al
    . National estimates of serum total 25-hydroxy vitamin D and metabolite concentrations measured by liquid chromatography—tandem mass spectrometry in the US population during 2007–2010. J Nutr 2016;146:1051–61.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Holick MF
    . Vitamin D: a D-lightful solution for health. J Investig Med Off Med 2011;59:872–80.
    OpenUrl
  6. 6.↵
    National Institutes of Health, Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. Published March 2, 2018. Updated August 12, 2022. Accessed February 9, 2022. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/.
  7. 7.↵
    1. Kulie T,
    2. Groff A,
    3. Redmer J,
    4. Hounshell J,
    5. Schrager S
    . Vitamin D: an evidence-based review. J Am Board Fam Med 2009;22:698–706.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Finley CR,
    2. Chan DS,
    3. Garrison S,
    4. et al
    . What are the most common conditions in primary care? Can Fam Physician 2018;64:832–40.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Ahmad FB,
    2. Anderson RN
    . The leading causes of death in the US for 2020. JAMA 2021;325:1829–30.
    OpenUrlPubMed
  10. 10.↵
    Food and Drug Administration. Comments to the Proposed Rule and the Supplemental Proposed Rule, Our Responses, and a Description of the Final Rule. Published May 27, 2016. Accessed June 9, 2022. Available from https://www.govinfo.gov/content/pkg/FR-2016-05-27/pdf/2016-11867.pdf.
  11. 11.↵
    1. Neale RE,
    2. Baxter C,
    3. Romero BD,
    4. et al
    . The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol 2022;10:120–8.
    OpenUrl
  12. 12.↵
    1. Zhang Y,
    2. Fang F,
    3. Tang J,
    4. et al
    . Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ 2019;366:l4673.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Moraes RB,
    2. Friedman G,
    3. Wawrzeniak IC,
    4. et al
    . Vitamin D deficiency is independently associated with mortality among critically ill patients. Clinics 2015;70:326–32.
    OpenUrlPubMed
  14. 14.↵
    1. Heath AK,
    2. Kim IY,
    3. Hodge AM,
    4. et al.
    Vitamin D status and mortality: a systematic review of observational studies. IJERPH 2019;16:383.
    OpenUrl
  15. 15.↵
    1. Shen H,
    2. Mei Y,
    3. Zhang K,
    4. Xu X
    . The effect of vitamin D supplementation on clinical outcomes for critically ill patients: a systemic review and meta-analysis of randomized clinical trials. Front Nutr 2021;8:664940.
    OpenUrl
  16. 16.↵
    1. Wang L,
    2. Song Y,
    3. Manson JE,
    4. et al
    . Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012;5:819–29.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Kunutsor SK,
    2. Apekey TA,
    3. Steur M
    . Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 2013;28:205–21.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Manson JE,
    2. Cook NR,
    3. Lee IM,
    4. et al
    . Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019;380:33–44.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Barbarawi M,
    2. Kheiri B,
    3. Zayed Y,
    4. et al
    . Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol 2019;4:765–76.
    OpenUrl
  20. 20.↵
    1. Arora P,
    2. Song Y,
    3. Dusek J,
    4. et al
    . Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 2015;131:254–62.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Zhang D,
    2. Cheng C,
    3. Wang Y,
    4. et al
    . Effect of vitamin D on blood pressure and hypertension in the general population: an update meta-analysis of cohort studies and randomized controlled trials. Prev Chronic Dis 2020;17:E03.
    OpenUrlPubMed
  22. 22.↵
    1. Alagacone S,
    2. Verga E,
    3. Verdolini R,
    4. Saifullah SM
    . The association between vitamin D deficiency and the risk of resistant hypertension. Clin Exp Hypertens 2020;42:177–80.
    OpenUrl
  23. 23.↵
    1. Witham MD,
    2. Ireland S,
    3. Houston JG,
    4. et al
    . Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 2014;63:706–12.
    OpenUrl
  24. 24.↵
    1. Choi YJ,
    2. Kim YH,
    3. Cho CH,
    4. et al.
    Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis. World J Gastroenterol 2015;21:8868–77.
    OpenUrl
  25. 25.↵
    1. McCullough ML,
    2. Zoltick ES,
    3. Weinstein SJ,
    4. et al
    . Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts. J Natl Cancer Inst 2019;111:158–69.
    OpenUrlPubMed
  26. 26.↵
    1. Zhang L,
    2. Zou H,
    3. Zhao Y,
    4. et al
    . Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis. BMJ Open 2019;9:e030513.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Bjelakovic G,
    2. Gluud LL,
    3. Nikolova D,
    4. et al
    . Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev 2014;CD007469.
  28. 28.↵
    1. Virtanen JK,
    2. Nurmi T,
    3. Aro A,
    4. et al
    . Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial—a randomized controlled trial. Am J Clin Nutr. Published online January 4 2022;nqab419.
  29. 29.↵
    1. Dimitrakopoulou VI,
    2. Tsilidis KK,
    3. Haycock PC,
    4. et al
    . Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ 2017;359:j4761.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Zdrenghea MT,
    2. Makrinioti H,
    3. Bagacean C,
    4. Bush A,
    5. Johnston SL,
    6. Stanciu LA
    . Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol 2017;27.
  31. 31.↵
    1. Jolliffe DA,
    2. Greiller CL,
    3. Mein CA,
    4. et al
    . Vitamin D receptor genotype influences risk of upper respiratory infection. Br J Nutr 2018;120:891–900.
    OpenUrl
  32. 32.↵
    1. Petrelli F,
    2. Luciani A,
    3. Perego G,
    4. Dognini G,
    5. Colombelli PL,
    6. Ghidini A
    . Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol 2021;211:105883.
    OpenUrl
  33. 33.↵
    1. Bassatne A,
    2. Basbous M,
    3. Chakhtoura M,
    4. El Zein O,
    5. Rahme M,
    6. El-Hajj Fuleihan G
    . The link between COVID-19 and vitamin D (VIVID): A systematic review and meta-analysis. Metabolism 2021;119:154753.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Teshome A,
    2. Adane A,
    3. Girma B,
    4. Mekonnen ZA
    . The impact of vitamin D level on COVID-19 infection: systematic review and meta-analysis. Front Public Health 2021;9:624559.
    OpenUrl
  35. 35.↵
    1. Chiodini I,
    2. Gatti D,
    3. Soranna D,
    4. et al
    . Vitamin D status and SARS-CoV-2 infection and COVID-19 clinical outcomes. Front Public Health 2021;9:736665.
  36. 36.↵
    1. Villasis-Keever MA,
    2. López-Alarcón MG,
    3. Miranda-Novales G,
    4. et al
    . Efficacy and safety of vitamin D supplementation to prevent COVID-19 in frontline healthcare workers. A randomized clinical trial. Arch Med Res 2022;53:423–30.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Martineau AR,
    2. Jolliffe DA,
    3. Hooper RL,
    4. et al
    . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017;356:i6583.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Stroehlein JK,
    2. Wallqvist J,
    3. Iannizzi C,
    4. et al
    . Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev 2021;CD015043.
  39. 39.↵
    1. Varikasuvu SR,
    2. Thangappazham B,
    3. Vykunta A,
    4. et al
    . COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2022;20:907–13.
    OpenUrl
  40. 40.↵
    1. Shah K,
    2. Saxena D,
    3. Mavalankar D
    . Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM Mon J Assoc Physicians 2021;114:175–81.
    OpenUrl
  41. 41.↵
    1. Thanapluetiwong S,
    2. Chewcharat A,
    3. Takkavatakarn K,
    4. Praditpornsilpa K,
    5. Eiam-Ong S,
    6. Susantitaphong P
    . Vitamin D supplement on prevention of fall and fracture: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2020;99:e21506.
    OpenUrl
  42. 42.↵
    1. Dhaliwal R,
    2. Aloia JF
    . Effect of vitamin D on falls and physical performance. Endocrinol Metab Clin North Am 2017;46:919–33.
    OpenUrl
  43. 43.↵
    1. Ling Y,
    2. Xu F,
    3. Xia X,
    4. et al
    . Vitamin D supplementation reduces the risk of fall in the vitamin D deficient elderly: an updated meta-analysis. Clin Nutr 2021;40:5531–7.
    OpenUrl
  44. 44.↵
    1. Sanders KM,
    2. Stuart AL,
    3. Williamson EJ,
    4. et al
    . Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815–22.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Bischoff-Ferrari HA,
    2. Dawson-Hughes B,
    3. Orav EJ,
    4. et al
    . Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 2016;176:175.
    OpenUrl
  46. 46.↵
    1. Smith LM,
    2. Gallagher JC,
    3. Suiter C
    . Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: A randomized clinical trial. J Steroid Biochem Mol Biol 2017;173:317–22.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Balion C,
    2. Griffith LE,
    3. Strifler L,
    4. et al
    . Vitamin D, cognition, and dementia: A systematic review and meta-analysis. Neurology 2012;79:1397–405.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Yang T,
    2. Wang H,
    3. Xiong Y,
    4. et al
    . Vitamin D supplementation improves cognitive function through reducing oxidative stress regulated by telomere length in older adults with mild cognitive impairment: a 12-month randomized controlled trial. JAD 2020;78:1509–18.
    OpenUrl
  49. 49.↵
    1. Goodwill AM,
    2. Szoeke C
    . A systematic review and meta-analysis of the effect of low vitamin D on cognition. J Am Geriatr Soc 2017;65:2161–8.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Jorde R,
    2. Kubiak J,
    3. Svartberg J,
    4. et al
    . Vitamin D supplementation has no effect on cognitive performance after four months in mid-aged and older subjects. J Neurol Sci 2019;396:165–71.
    OpenUrl
  51. 51.↵
    1. Annweiler C,
    2. Dursun E,
    3. Féron F,
    4. et al
    . Vitamin D and cognition in older adults: updated international recommendations. J Intern Med 2015;277:45–57.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Annweiler C
    . Vitamin D-mentia: Is vitamin D optional or essential for preventing late-life cognitive decline? J Am Geriatr Soc 2017;65:2155–7.
    OpenUrl
  53. 53.↵
    1. Casseb GAS,
    2. Kaster MP,
    3. Rodrigues ALS
    . Potential role of vitamin D for the management of depression and anxiety. CNS Drugs 2019;33:619–37.
    OpenUrl
  54. 54.↵
    1. Kim SY,
    2. Jeon SW,
    3. Lim WJ,
    4. et al
    . The relationship between serum vitamin D levels, C-reactive protein, and anxiety symptoms. Psychiatry Investig 2020;17:312–9.
    OpenUrl
  55. 55.↵
    1. Anglin RES,
    2. Samaan Z,
    3. Walter SD,
    4. McDonald SD
    . Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry J Psychiatry 2013;202:100–7.
    OpenUrl
  56. 56.↵
    1. Okereke OI,
    2. Reynolds CF,
    3. Mischoulon D,
    4. et al
    . Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. JAMA 2020;324:471–80.
    OpenUrl
  57. 57.↵
    1. Jorde R,
    2. Kubiak J
    . No improvement in depressive symptoms by vitamin D supplementation: results from a randomised controlled trial. J Nutr Sci 2018;7:e30.
    OpenUrl
  58. 58.↵
    1. Shaffer JA,
    2. Edmondson D,
    3. Wasson LT,
    4. et al
    . Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med 2014;76:190–6.
    OpenUrlCrossRefPubMedWeb of Science
  59. 59.↵
    1. Wu Z,
    2. Malihi Z,
    3. Stewart AW,
    4. et al.
    The association between vitamin D concentration and pain: a systematic review and meta-analysis. Public Health Nutr 2018;21:2022–37.
    OpenUrl
  60. 60.↵
    1. Ali OME
    . Prevalence of vitamin D deficiency and its relationship with clinical outcomes in patients with fibromyalgia: a systematic review of the literature. SN Compr Clin Med 2022;4:38.
    OpenUrl
  61. 61.↵
    1. Helde-Frankling M,
    2. Björkhem-Bergman L
    . Vitamin D in pain management. IJMS 2017;18:2170.
    OpenUrl
  62. 62.↵
    1. Straube S,
    2. Derry S,
    3. Straube C,
    4. Moore RA
    . Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev 2015;CD015043.
  63. 63.↵
    1. Yilmaz R,
    2. Salli A,
    3. Cingoz HT,
    4. et al.
    Efficacy of vitamin D replacement therapy on patients with chronic nonspecific widespread musculoskeletal pain with vitamin D deficiency. Int J Rheum Dis 2016;19:1255–62.
    OpenUrl
  64. 64.↵
    1. Pagliai G,
    2. Giangrandi I,
    3. Dinu M,
    4. et al.
    Nutritional interventions in the management of fibromyalgia syndrome. Nutrients 2020;12:12092525.
    OpenUrl
  65. 65.↵
    1. Ogurtsova K,
    2. da Rocha Fernandes JD,
    3. Huang Y,
    4. et al
    . IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50.
    OpenUrlCrossRefPubMed
  66. 66.↵
    1. Huang Y,
    2. Cai X,
    3. Mai W,
    4. et al.
    Association between prediabetes and risk of cardiovascular disease and all-cause mortality: systematic review and meta-analysis. BMJ 2016;i5953.
  67. 67.↵
    1. Berridge MJ
    . Vitamin D deficiency and diabetes. Biochem J 2017;474:1321–32.
    OpenUrlAbstract/FREE Full Text
  68. 68.↵
    1. Narayan KMV,
    2. Boyle JP,
    3. Thompson TJ,
    4. et al.
    Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007;30:1562–6.
    OpenUrlAbstract/FREE Full Text
  69. 69.↵
    1. Rafiq S,
    2. Jeppesen P
    . Body mass index, vitamin D, and type 2 diabetes: a systematic review and meta-analysis. Nutrients 2018;10:1182.
    OpenUrl
  70. 70.↵
    1. Barbarawi M,
    2. Zayed Y,
    3. Barbarawi O,
    4. et al
    . Effect of vitamin D supplementation on the incidence of diabetes mellitus. J Clin Endocrinol Metab 2020;105:2857–68.
    OpenUrlPubMed
  71. 71.↵
    1. Kawahara T,
    2. Suzuki G,
    3. Mizuno S,
    4. et al
    . Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. BMJ. 2022;e066222.
  72. 72.↵
    1. Hu Z,
    2. Chen J,
    3. Sun X,
    4. et al.
    Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: A meta-analysis of interventional studies. Medicine (Baltimore) 2019;98:e14970.
    OpenUrl
  73. 73.↵
    1. Palmer DJ
    . Vitamin D and the development of atopic eczema. J Clin Med 2015;4:1036–50.
    OpenUrl
  74. 74.↵
    1. Williams H,
    2. Chalmers J
    . Prevention of atopic dermatitis. Acta Derm Venereol 2020;100:adv00166.
    OpenUrl
  75. 75.↵
    1. Hattangdi-Haridas SR,
    2. Lanham-New SA,
    3. Wong WHS
    , et al. Vitamin D deficiency and effects of vitamin D supplementation on disease severity in patients with atopic dermatitis: a systematic review and meta-analysis in adults and children. Nutrients 2019;11:1854.
    OpenUrlPubMed
  76. 76.↵
    1. Kim MJ,
    2. Kim SN,
    3. Lee YW,
    4. et al.
    Vitamin D status and efficacy of vitamin D supplementation in atopic dermatitis: a systematic review and meta-analysis. Nutrients 2016;8:789.
    OpenUrl
  77. 77.↵
    1. Wang SS,
    2. Hon KL,
    3. Kong AP,
    4. et al
    . Vitamin D deficiency is associated with diagnosis and severity of childhood atopic dermatitis. Pediatr Allergy Immunol 2014;25:30–5.
    OpenUrlCrossRefPubMed
  78. 78.↵
    1. Vähävihu K,
    2. Ala-Houhala M,
    3. Peric M,
    4. et al
    . Narrowband ultraviolet B treatment improves Vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010;163:321–8.
    OpenUrlCrossRefPubMedWeb of Science
  79. 79.↵
    1. Mangin M,
    2. Sinha R,
    3. Fincher K
    . Inflammation and vitamin D: the infection connection. Inflamm Res Off Res 2014;63:803–19.
    OpenUrl
  80. 80.↵
    1. Yepes-Nuñez JJ,
    2. Brożek JL,
    3. Fiocchi A,
    4. et al
    . Vitamin D supplementation in primary allergy prevention: Systematic review of randomized and non-randomized studies. Allergy 2018;73:37–49.
    OpenUrl
  81. 81.↵
    1. Kim G,
    2. Bae JH
    . Vitamin D and atopic dermatitis: A systematic review and meta-analysis. Nutrition 2016;32:913–20.
    OpenUrl
  82. 82.↵
    1. Raj KAP,
    2. Handa S,
    3. Narang T,
    4. et al.
    Correlation of serum vitamin D levels with severity of pediatric atopic dermatitis and the impact of vitamin D supplementation on treatment outcomes. J Dermatolog Treat 2022;33:1397–400.
    OpenUrl
  83. 83.↵
    1. Mansour NO,
    2. Mohamed AA,
    3. Hussein M,
    4. et al
    . The impact of vitamin D supplementation as an adjuvant therapy on clinical outcomes in patients with severe atopic dermatitis: A randomized controlled trial. Pharmacol Res Perspect 2020;8:e00679.
  84. 84.↵
    1. Kiely ME,
    2. Wagner CL,
    3. Roth DE
    . Vitamin D in pregnancy: Where we are and where we should go. J Steroid Biochem Mol Biol 2020;201:105669.
    OpenUrlPubMed
  85. 85.↵
    1. Urrutia RP,
    2. Thorp JM
    . Vitamin D in pregnancy: current concepts. Curr Opin Obstet Gynecol 2012;24:57–64.
    OpenUrlCrossRefPubMed
  86. 86.↵
    1. Sharif K,
    2. Sharif Y,
    3. Watad A,
    4. et al
    . Vitamin D, autoimmunity and recurrent pregnancy loss: More than an association. Am J Reprod Immunol N Immunol 2018;80:e12991.
    OpenUrl
  87. 87.↵
    1. Ji J,
    2. Zhai H,
    3. Zhou H,
    4. et al.
    The role and mechanism of vitamin D-mediated regulation of treg/Th17 balance in recurrent pregnancy loss. Am J Reprod Immunol N Immunol 2019;81:e13112.
    OpenUrl
  88. 88.↵
    1. Tamblyn JA,
    2. Pilarski NSP,
    3. Markland AD,
    4. et al
    . Vitamin D and miscarriage: a systematic review and meta-analysis. Fertil Steril 2022;118:111–22.
  89. 89.↵
    1. Mirzakhani H,
    2. Litonjua AA,
    3. McElrath TF,
    4. et al
    . Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest 2016;126:4702–15.
    OpenUrl
  90. 90.↵
    1. Khaing W,
    2. Vallibhakara SAO,
    3. Tantrakul V,
    4. et al
    . Calcium and vitamin D supplementation for prevention of preeclampsia: a systematic review and network meta-analysis. Nutrients 2017;9:1141.
    OpenUrl
  91. 91.↵
    1. Yue CY,
    2. Ying CM
    . Sufficience serum vitamin D before 20 weeks of pregnancy reduces the risk of gestational diabetes mellitus. Nutr Metab (Lond) 2020;17:89.
    OpenUrl
  92. 92.↵
    1. Kalok A
    . Maternal serum vitamin D and spontaneous preterm birth. Clin Exp Obstet Gynecol 2020;47:16–20.
    OpenUrl
  93. 93.↵
    1. McDonnell SL,
    2. Baggerly KA,
    3. Baggerly CA,
    4. et al
    . Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PloS One 2017;12:e0180483.
    OpenUrl
  94. 94.↵
    1. Wagner CL,
    2. Taylor SN,
    3. Dawodu A,
    4. et al.
    Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients 2012;4:208–30.
    OpenUrlCrossRefPubMed
  95. 95.↵
    1. Zhao R,
    2. Zhou L,
    3. Wang S,
    4. et al.
    Effect of maternal vitamin D status on risk of adverse birth outcomes: a systematic review and dose-response meta-analysis of observational studies. Eur J Nutr 2022;61:2881–907.
    OpenUrl
  96. 96.↵
    1. Qureshi S,
    2. Wilkinson JE
    . Vitamin D supplementation for women during pregnancy. Am Fam Physician 2013;87:314.
    OpenUrl
  97. 97.↵
    1. Nørrisgaard PE,
    2. Haubek D,
    3. Kühnisch J,
    4. et al
    . Association of high-dose vitamin D supplementation during pregnancy with the risk of enamel defects in offspring: a 6-year follow-up of a randomized clinical trial. JAMA Pediatr 2019;173:924–930.
    OpenUrl
  98. 98.↵
    1. Liu Y,
    2. Ding C,
    3. Xu R,
    4. et al
    . Effects of vitamin D supplementation during pregnancy on offspring health at birth: a meta-analysis of randomized controlled trails. Clin Nutr Edinb Nutr 2022;41:1532–1540.
    OpenUrl
  99. 99.↵
    1. Hollis BW,
    2. Wagner CL
    . Substantial vitamin D supplementation is required during the prenatal period to improve birth outcomes. Nutrients 2022;14:899.
    OpenUrl
  100. 100.↵
    American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 495: Vitamin D screening and supplementation during pregnancy. Obstet Gynecol 2011;118:197–198.
    OpenUrlCrossRefPubMed
  101. 101.↵
    1. Gila-Diaz A,
    2. Arribas SM,
    3. Algara A,
    4. et al
    . A review of bioactive factors in human breastmilk: a focus on prematurity. Nutrients 2019;11:1307.
    OpenUrlCrossRefPubMed
  102. 102.↵
    1. Chatterton DEW,
    2. Nguyen DN,
    3. Bering SB,
    4. Sangild PT
    . Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol 2013;45:1730–1747.
    OpenUrlCrossRefPubMed
  103. 103.↵
    1. Andreas NJ,
    2. Kampmann B,
    3. Mehring Le-Doare K
    . Human breast milk: a review on its composition and bioactivity. Early Hum Dev 2015;91:629–635.
    OpenUrlCrossRefPubMed
  104. 104.↵
    Breastfeeding, Family Physicians Supporting (Position Paper). Published 2001. Updated April 2021. Accessed March 9, 2022. Available from: https://www.aafp.org/about/policies/all/breastfeeding-position-paper.html.
  105. 105.↵
    American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 756. Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol 2018;132:e187–e196.
    OpenUrl
  106. 106.↵
    1. Wagner CL,
    2. Greer FR
    . Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142–1152.
    OpenUrlCrossRefPubMedWeb of Science
  107. 107.↵
    1. O’Callaghan KM,
    2. Taghivand M,
    3. Zuchniak A,
    4. et al
    . Vitamin D in breastfed infants: systematic review of alternatives to daily supplementation. Adv Nutr 2019;nmz098.
  108. 108.↵
    1. Tung KTS,
    2. Wong RS,
    3. Tsang HW,
    4. et al
    . An assessment of risk factors for insufficient levels of vitamin D during early Infancy. Nutrients 2021;13:1068.
    OpenUrl
  109. 109.↵
    1. Kazemain E,
    2. Ansari S,
    3. Davoodi SH,
    4. et al
    . The effect of maternal vitamin D supplementation on vitamin D status of exclusively breastfeeding mothers and their nursing infants: a systematic review and meta-analysis of randomized clinical trials. Adv Nutr 2021;nmab126.
  110. 110.↵
    1. Sen S,
    2. Penfield-Cyr A,
    3. Hollis BW,
    4. Wagner CL
    . Maternal obesity, 25-hydroxy vitamin D concentration, and bone density in breastfeeding dyads. J Pediatr 2017;187:147–152.
    OpenUrl
  111. 111.↵
    1. Chalcraft JR,
    2. Cardinal LM,
    3. Wechsler PJ,
    4. et al
    . Vitamin D synthesis following a single bout of sun exposure in older and younger men and women. Nutrients 2020;12:2237.
    OpenUrl
  112. 112.↵
    1. Nadeem S,
    2. Munim TF,
    3. Hussain HF,
    4. Hussain DF
    . Determinants of vitamin D deficiency in asymptomatic healthy young medical students. Pak J Med Sci 2018;34:1248–1252.
    OpenUrl
  113. 113.↵
    1. Brown LL,
    2. Cohen B,
    3. Tabor D,
    4. et al.
    The vitamin D paradox in Black Americans: a systems-based approach to investigating clinical practice, research, and public health expert panel meeting report. BMC Proc 2018;12:6–6.
    OpenUrl
  114. 114.↵
    1. Vavricka SR,
    2. Rogler G
    . Intestinal absorption and vitamin levels: is a new focus needed? Dig Dis 2012;30:73–80.
    OpenUrlCrossRefPubMed
  115. 115.↵
    1. Ekwaru JP,
    2. Zwicker JD,
    3. Holick MF,
    4. et al.
    The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxy vitamin D in healthy volunteers. PLoS ONE 2014;9:e111265.
    OpenUrlCrossRef
  116. 116.↵
    1. Aarts E,
    2. van Groningen L,
    3. Horst R,
    4. et al
    . Vitamin D absorption: consequences of gastric bypass surgery. Eur J Endocrinol 2011;164:827–832.
    OpenUrlAbstract/FREE Full Text
  117. 117.↵
    1. LeFevre ML
    . Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015;162:133–140.
    OpenUrlCrossRefPubMed
  118. 118.↵
    1. Burnett-Bowie SAM,
    2. Cappola AR
    . The USPSTF 2021 recommendations on screening for asymptomatic vitamin D deficiency in adults: the challenge for clinicians continues. JAMA 2021;325:1401–1402.
    OpenUrl
  119. 119.↵
    1. Pilz S,
    2. Zittermann A,
    3. Trummer C,
    4. et al
    . Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect 2019;8:R27–R43.
    OpenUrlPubMed
  120. 120.↵
    1. Parva NR,
    2. Tadepalli S,
    3. Singh P,
    4. et al
    . Prevalence of vitamin D deficiency and associated risk factors in the US population. Cureus 2018;10:e2741.
    OpenUrl
  121. 121.
    US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement. JAMA 2018;319(16):1696–1704.
  122. 122.
    US Preventive Services Task Force. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force recommendation statement. JAMA 2018;319:1592–1599.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 35 (6)
The Journal of the American Board of Family Medicine
Vol. 35, Issue 6
November/December 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions
William Michael, Allison Diane Couture, Matthew Swedlund, Adrienne Hampton, Anne Eglash, Sarina Schrager
The Journal of the American Board of Family Medicine Dec 2022, 35 (6) 1217-1229; DOI: 10.3122/jabfm.2022.220115R1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions
William Michael, Allison Diane Couture, Matthew Swedlund, Adrienne Hampton, Anne Eglash, Sarina Schrager
The Journal of the American Board of Family Medicine Dec 2022, 35 (6) 1217-1229; DOI: 10.3122/jabfm.2022.220115R1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Conclusion
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Clinically Useful Family Medicine Research
  • Google Scholar

More in this TOC Section

  • Interpretating Normal Values and Reference Ranges for Laboratory Tests
  • Non-Surgical Management of Urinary Incontinence
  • Screening and Diagnosis of Type 2 Diabetes in Sickle Cell Disease
Show more Clinical Review

Similar Articles

Keywords

  • Atopic Dermatitis
  • Cardiovascular Diseases
  • Child Health
  • Chronic Pain
  • COVID-19
  • Dementia
  • Depression
  • Dietary Supplements
  • Family Medicine
  • Geriatrics
  • Hypertension
  • Meta-Analysis
  • Obstetrics
  • Prenatal Care
  • Primary Health Care
  • Type 2 Diabetes
  • Vitamin D

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire